The critical role of vascular endothelial growth factor in pulmonary vascular remodeling after lung injury

Shock

Volumn 28, Issue 1, 2007, Pages 4-14

  Lahm, Tim ^a   Crisostomo, Paul R ^a   Markel, Troy A ^a   Wang, Meijing ^a   Lillemoe, Keith D ^a   Meldrum, Daniel R ^a,b  

^a INDIANA UNIVERSITY   (United States)

^b Emerson Hall 215 ^*  (United States)

Author keywords

Acute respiratory distress syndrome; Apoptosis; Bronchopulmonary dysplasia; Emphysema; Intracellular signaling; Pulmonary hypertension; Pulmonary vascular remodeling; Right ventricular hypertrophy

Indexed keywords

ALPHA 1 ANTITRYPSIN; ANGIOSTATIN; OXYGEN; RECOMBINANT VASCULOTROPIN; SEMAXANIB; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ACUTE LUNG INJURY; ATHEROSCLEROTIC PLAQUE; BIOLOGICAL ACTIVITY; CAPILLARY LEAK SYNDROME; CIGARETTE SMOKING; CORONARY ARTERY DISEASE; DIABETES MELLITUS; EMPHYSEMA; ENDOTHELIUM CELL; GENE TRANSFER; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE HYPERTROPHY; HEMATOPOIETIC STEM CELL; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPOXIA; KNOCKOUT MOUSE; LUNG BLOOD VESSEL; LUNG DEVELOPMENT; LUNG DYSPLASIA; LUNG INJURY; MOUSE STRAIN; NONHUMAN; NONVIRAL GENE THERAPY; OXYGEN SUPPLY; PATHOGENESIS; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; RAT STRAIN; REVIEW; SIGNAL TRANSDUCTION;

ADULT; ANIMALS; BRONCHOPULMONARY DYSPLASIA; EMPHYSEMA; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; HUMANS; HYPERTENSION, PULMONARY; INFANT, NEWBORN; LUNG; LUNG DISEASES; MODELS, BIOLOGICAL; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 34250746913     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/shk.0b013e31804d1998     Document Type: Review

References (148)

1. Michiels C: Endothelial cell functions. J Cell Physiol 196:430-443, 2003.
2. Maruyama I: Biology of endothelium. Lupus 7(suppl 2):41-43, 1998.
3. Tsai BM, Wang M, Turrentine MW, Mahomed Y, Brown JW, Meldrum DR: Hypoxic pulmonary vasoconstriction in cardiothoracic surgery: basic mechanisms to potential therapies. Ann Thorac Surg 78:360-368, 2004.
4. Farber HW, Loscalzo J: Pulmonary arterial hypertension. N Engl J Med 351:1655-1665, 2004.
5. McLaughlin VV, McGoon MD: Pulmonary arterial hypertension. Circulation 114:1417-1431, 2006.
6. Morrell ED, Tsai BM, Crisostomo PR, Hammoud ZT, Meldrum DR: Experimental therapies for hypoxia-induced pulmonary hypertension during acute lung injury. Shock 25:214-226, 2006.
7. Morrell ED, Tsai BM, Crisostomo PR, Wang M, Markel TA, Lillemoe KD, Meldrum DR: Therapeutic concepts for hypoxic pulmonary vasoconstriction involving ion regulation and the smooth muscle contractile apparatus. J Mol Cell Cardiol 40:751-760, 2006.
8. Petrache I, Fijalkowska I, Medler TR, Skirball J, Cruz P, Zhen L, Petrache HI, Flotte TR, Tuder RM: {alpha}-1 antitrypsin inhibits caspase-3 activity, preventing lung endothelial cell apoptosis. Am J Pathol 169:1155-1166, 2006.
9. Tuder RM, Petrache I, Elias JA, Voelkel NF, Henson PM: Apoptosis and emphysema: the missing link. Am J Respir Cell Mol Biol 28:551-554, 2003.
10. Kuenen BC, Levi M, Meijers JC, Kakkar AK, van Hinsbergh VW, Kostense PJ, Pinedo HM, Hoekman K: Analysis of coagulation cascade and endothelial cell activation during inhibition of vascular endothelial growth factor/ vascular endothelial growth factor receptor pathway in cancer patients. Arterioscler Thromb Vasc Biol 22:1500-1505, 2002.
11. Ferrara N: Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 25:581-611, 2004.
12. Voelkel NF, Vandivier RW, Tuder RM: Vascular endothelial growth factor in the lung. Am J Physiol Lung Cell Mol Physiol 290:L209-L221, 2006.
13. Park JE, Keller GA, Ferrara N: The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol Biol Cell 4:1317-1326, 1993.
14. Voelkel NF, Cool C, Taraceviene-Stewart L, Geraci MW, Yeager M, Bull T, Kasper M, Tuder RM: Janus face of vascular endothelial growth factor: the obligatory survival factor for lung vascular endothelium controls precapillary artery remodeling in severe pulmonary hypertension. Crit Care Med 30(suppl):251-256, 2002.
15. Monacci WT, Merrill MJ, Oldfield EH: Expression of vascular permeability factor/vascular endothelial growth factor in normal rat tissues. Am J Physiol 264:C995-C1002, 1993.
16. Terman BI, Dougher-Vermazen M, Carrion ME, Dimitrov D, Armellino DC, Gospodarowicz D, Bohlen P: Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Commun 187:1579-1586, 1992.
17. Terman BI, Carrion ME, Kovacs E, Rasmussen BA, Eddy RL, Shows TB: Identification of a new endothelial cell growth factor receptor tyrosine kinase. Oncogene 6:1677-1683, 1991.
18. He H, Venema VJ, Gu X, Venema RC, Marrero MB, Caldwell RB: Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1/KDR activation of c-Src. J Biol Chem 274:25130-25135, 1999.
19. Ishida A, Murray J, Saito Y, Kanthou C, Benzakour O, Shibuya M, Wijelath ES: Expression of vascular endothelial growth factor receptors in smooth muscle cells. J Cell Physiol 188:359-368, 2001.
20. Jakeman LB, Winer J, Bennett GL, Altar CA, Ferrara N: Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues. J Clin Invest 89:244-253, 1992.
21. Ahmad S, Hewett PW, Wang P, Al-Ani B, Cudmore M, Fujisawa T, Haigh JJ, le Noble F, Wang L, Mukhopadhyay D, et al.: Direct evidence for endothelial vascular endothelial growth factor receptor-1 function in nitric oxide-mediated angiogenesis. Circ Res 99:715-722, 2006.
22. Fong GH, Rossant J, Gertsenstein M, Breitman ML: Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376:66-70, 1995.
23. Matsumoto T, Mugishima H: Signal transduction via vascular endothelial growth factor (VEGF) receptors and their roles in atherogenesis. J Atheroscler Thromb 13:130-135, 2006.
24. Ku DD, Zaleski JK, Liu S, Brock TA: Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. Am J Physiol 265:H586-H592, 1993.
25. Ferrara N, Hillan KJ, Gerber HP, Novotny W: Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat Rev Drug Discov 3:391-400, 2004.
26. Dimmeler S, Zeiher AM: Nitric oxide - an endothelial cell survival factor. Cell Death Differ 6:964-968, 1999.
27. Fukumura D, Gohongi T, Kadambi A, Izumi Y, Ang J, Yun CO, Buerk DG, Huang PL, Jain RK: Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc Natl Acad Sci U S A 98:2604-2609, 2001.
28. Aicher A, Heeschen C, Mildner-Rihm C, Urbich C, Ihling C, Technau-Ihling K, Zeiher AM, Dimmeler S: Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med 9:1370-1376, 2003.
29. Dimmeler S, Zeiher AM: Vascular repair by circulating endothelial progenitor cells: the missing link in atherosclerosis? J Mol Med 82:671-677, 2004.
30. Urbich C, Dimmeler S: Risk factors for coronary artery disease, circulating endothelial progenitor cells, and the role of HMG-CoA reductase inhibitors. Kidney Int 67:1672-1676, 2005.
31. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, Zeiher AM, Dimmeler S: Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89:E1-E7, 2001.
32. Dvorak HF, Brown LF, Detmar M, Dvorak AM: Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146:1029-1039, 1995.
33. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306-1309, 1989.
34. Waltenberger J, Claesson-Welsh L, Siegbahn A, Shibuya M, Heldin CH: Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J Biol Chem 269:26988-26995, 1994.
35. Chen Y, Medhora M, Falck JR, Pritchard KA Jr, Jacobs ER: Mechanisms of activation of eNOS by 20-HETE and VEGF in bovine pulmonary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol 291:L378-L385, 2006.
36. Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E, Frisch S, Reed JC: Regulation of cell death protease caspase-9 by phosphorylation. Science 282:1318-1321, 1998.
37. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME: Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91:231-241, 1997.
38. Gratton JP, Morales-Ruiz M, Kureishi Y, Fulton D, Walsh K, Sessa WC: Akt down-regulation of p38 signaling provides a novel mechanism of vascular endothelial growth factor-mediated cytoprotection in endothelial cells. J Biol Chem 276:30359-30365, 2001.
39. Stoeltzing O, Meric-Bernstam F, Ellis LM: Intracellular signaling in tumor and endothelial cells: the expected and, yet again, the unexpected. Cancer Cell 10:89-91, 2006.
40. Jacobs ER, Zhu D, Gruenloh S, Lopez B, Medhora M: VEGF-induced relaxation of pulmonary arteries is mediated by endothelial cytochrome P-450 hydroxylase. Am J Physiol Lung Cell Mol Physiol 291:L369-L377, 2006.
41. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML, Schuh AC: Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376:62-66, 1995.
42. Compernolle V, Brusselmans K, Acker T, Hoet P, Tjwa M, Beck H, Plaisance S, Dor Y, Keshet E, Lupu F, et al.: Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nat Med 8:702-710, 2002.
43. Brown KR, England KM, Goss KL, Snyder JM, Acarregui MJ: VEGF induces airway epithelial cell proliferation in human fetal lung in vitro. Am J Physiol Lung Cell Mol Physiol 281:L1001-L1010, 2001.
44. Chen WS, Kitson RP, Goldfarb RH: Modulation of human NK cell lines by vascular endothelial growth factor and receptor VEGFR-1 (FLT-1). In Vivo 16:439-445, 2002.
45. Gerber HP, Malik AK, Solar GP, Sherman D, Liang XH, Meng G, Hong K, Marsters JC, Ferrara N: VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism. Nature 417:954-958, 2002.
46. Farahani M, Treweeke AT, Toh CH, Till KJ, Harris RJ, Cawley JC, Zuzel M, Chen H: Autocrine VEGF mediates the antiapoptotic effect of CD154 on CLL cells. Leukemia 19:524-530, 2005.
47. Duyndam MC, Hilhorst MC, Schluper HM, Verheul HM, van Diest PJ, Kraal G, Pinedo HM, Boven E: Vascular endothelial growth factor-65 overexpression stimulates angiogenesis and induces cyst formation and macrophage infiltration in human ovarian cancer xenografts. Am J Pathol 160:537-548, 2002.
48. Norrby K: Mast cells and angiogenesis. Apmis 110:355-371, 2002.
49. Feistritzer C, Kaneider NC, Sturn DH, Mosheimer BA, Kahler CM, Wiedermann CJ: Expression and function of the vascular endothelial growth factor receptor FLT-1 in human eosinophils. Am J Respir Cell Mol Biol 30:729-735, 2004.
50. Gabrilovich DI, Ishida T, Nadaf S, Ohm JE, Carbone DP: Antibodies to vascular endothelial growth factor enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function. Clin Cancer Res 5:2963-2970, 1999.
51. Lambrechts D, Storkebaum E, Morimoto M, Del-Favero J, Desmet F, Marklund SL, Wyns S, Thijs V, Andersson J, van Marion I, et al.: VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Genet 34:383-394, 2003.
52. Wang M, Tsai BM, Crisostomo PR, Meldrum DR: Pretreatment with adult progenitor cells improves recovery and decreases native myocardial proinflammatory signaling after ischemia. Shock 25:454-459, 2006.
53. Wang M, Crisostomo PR, Herring C, Meldrum KK, Meldrum DR: Human progenitor cells from bone marrow or adipose tissue produce VEGF, HGF, and IGF-I in response to TNF by a p38 MAPK-dependent mechanism. Am J Physiol Regul Integr Comp Physiol 291:R880-R884, 2006.
54. Rivard A, Fabre JE, Silver M, Chen D, Murohara T, Kearney M, Magner M, Asahara T, Isner JM: Age-dependent impairment of angiogenesis. Circulation 99:111-120, 1999.
55. Henrich D, Hahn P, Wahl M, Wilhelm K, Dernbach E, Dimmeler S, Marzi I: Serum derived from multiple trauma patients promotes the differentiation of endothelial progenitor cells in vitro: possible role of transforming growth factor-beta1 and vascular endothelial growth factor165. Shock 2:13-16, 2004.
56. Ayala A, Perrin MM, Wang P, Ertel W, Chaudry IH: Hemorrhage induces enhanced Kupffer cell cytotoxicity while decreasing peritoneal or splenic macrophage capacity. Involvement of cell-associated tumor necrosis factor and reactive nitrogen. J Immunol 147:4147-4154, 1991.
57. Shweiki D, Itin A, Soffer D, Keshet E: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843-845, 1992.
58. Tuder RM, Flook BE, Voelkel NF: Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide. J Clin Invest 95:1798-1807, 1995.
59. Semenza GL: Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3:721-732, 2003.
60. Resnick N, Gimbrone MA Jr: Hemodynamic forces are complex regulators of endothelial gene expression. FASEB J 9:874-882, 1995.
61. Voelkel NF, Tuder RM: Hypoxia-induced pulmonary vascular remodeling: a model for what human disease? J Clin Invest 106:733-738, 2000.
62. Fosslien E: Review: molecular pathology of cyclooxygenase-2 in cancer-induced angiogenesis. Ann Clin Lab Sci 31:325-348, 2001.
63. Choy H, Milas L: Enhancing radiotherapy with cyclooxygenase-2 enzyme inhibitors: a rational advance? J Natl Cancer Inst 95:1440-1452, 2003.
64. Spicer J, Harper P: Targeted therapies for non-small cell lung cancer. Int J Clin Pract 59:1055-1062, 2005.
65. Akeson AL, Greenberg JM, Cameron JE, Thompson FY, Brooks SK, Wiginton D, Whitsett JA: Temporal and spatial regulation of VEGF-A controls vascular patterning in the embryonic lung. Dev Biol 264:443-455, 2003.
66. Gerber HP, Hillan KJ, Ryan AM, Kowalski J, Keller GA, Rangell L, Wright BD, Radtke F, Aguet M, Ferrara N: VEGF is required for growth and survival in neonatal mice. Development 126:1149-1159, 1999.
67. Le Cras TD, Markham NE, Tuder RM, Voelkel NF, Abman SH: Treatment of newborn rats with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure. Am J Physiol Lung Cell Mol Physiol 283: L555-L562, 2002.
68. Jakkula M, Le Cras TD, Gebb S, Hirth KP, Tuder RM, Voelkel NF, Abman SH: Inhibition of angiogenesis decreases alveolarization in the developing rat lung. Am J Physiol Lung Cell Mol Physiol 279:L600-L607, 2000.
69. Maniscalco WM, Watkins RH, D'Angio CT, Ryan RM: Hyperoxic injury decreases alveolar epithelial cell expression of vascular endothelial growth factor (VEGF) in neonatal rabbit lung. Am J Respir Cell Mol Biol 16:557-567, 1997.
70. Lassus P, Ristimaki A, Ylikorkala O, Viinikka L, Andersson S: Vascular endothelial growth factor in human preterm lung. Am J Respir Crit Care Med 159:1429-1433, 1999.
71. Bhatt AJ, Pryhuber GS, Huyck H, Watkins RH, Metlay LA, Maniscalco WM: Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia. Am J Respir Crit Care Med 164:1971-1980, 2001.
72. Thebaud B, Ladha F, Michelakis ED, Sawicka M, Thurston G, Eaton F, Hashimoto K, Harry G, Haromy A, Korbutt G, et al.: Vascular endothelial growth factor gene therapy increases survival, promotes lung angiogenesis, and prevents alveolar damage in hyperoxia-induced lung injury: evidence that angiogenesis participates in alveolarization. Circulation 112:2477-2486, 2005.
73. Kunig AM, Balasubramaniam V, Markham NE, Morgan D, Montgomery G, Grover TR, Abman SH: Recombinant human VEGF treatment enhances alveolarization after hyperoxic lung injury in neonatal rats. Am J Physiol Lung Cell Mol Physiol 289:L529-L535, 2005.
74. Klekamp JG, Jarzecka K, Perkett EA: Exposure to hyperoxia decreases the expression of vascular endothelial growth factor and its receptors in adult rat lungs. Am J Pathol 154:823-831, 1999.
75. Hamacher J, Lucas R, Lijnen HR, Buschke S, Dunant Y, Wendel A, Grau GE, Suter PM, Ricou B: Tumor necrosis factor-alpha and angiostatin are mediators of endothelial cytotoxicity in bronchoalveolar lavages of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 166: 651-656, 2002.
76. Abadie Y, Bregeon F, Papazian L, Lange F, Chailley-Heu B, Thomas P, Duvaldestin P, Adnot S, Maitre B, Delclaux C: Decreased VEGF concentration in lung tissue and vascular injury during ARDS. Eur Respir J 25:139-146, 2005.
77. Haimovitz-Friedman A, Cordon-Cardo C, Bayoumy S, Garzotto M, McLoughlin M, Gallily R, Edwards CK III, Schuchman EH, Fuks Z, Kolesnick R: Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation. J Exp Med 186:1831-1841, 1997.
78. Lindsey HJ, Kisala JM, Ayala A, Lehman D, Herdon CD, Chaudry IH: Pentoxifylline attenuates oxygen-induced lung injury. J Surg Res 56:543-548, 1994.
79. Angele MK, Smail N, Wang P, Cioffi WG, Bland KI, Chaudry IH: L-arginine restores the depressed cardiac output and regional perfusion after trauma-hemorrhage. Surgery 124:394-401, 1998. discussion 401-402.
80. Murphey ED, Sherwood ER: Bacterial clearance and mortality are not improved by a combination of IL-10 neutralization and IFN-gamma administration in a murine model of post-CLP immunosuppression. Shock 26:417-424, 2006.
81. Kaufmann I, Hoelzl A, Schliephake F, Hummel T, Chouker A, Peter K, Thiel M: Polymorphonuclear leukocyte dysfunction syndrome in patients with increasing sepsis severity. Shock 26:254-261, 2006.
82. Nakagawa NK, Nogueira RA, Correia CJ, Shiwa SR, Costa Cruz JW, Poli de Figueiredo LF, Rocha ESM, Sannomiya P: Leukocyte-endothelium interactions after hemorrhagic shock/reperfusion and cecal ligation/puncture: an intravital microscopic study in rat mesentery. Shock 26:180-186, 2006.
83. Yu M, Wang H, Ding A, Golenbock DT, Latz E, Czura CJ, Fenton MJ, Tracey KJ, Yang H: HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. Shock 26:174-179, 2006.
84. Yu HP, Yang S, Hsieh YC, Choudhry MA, Bland KI, Chaudry IH: Maintenance of lung myeloperoxidase activity in proestrus females after trauma-hemorrhage: upregulation of heme oxygenase-1. Am J Physiol Lung Cell Mol Physiol 291:L400-L406, 2006.
85. Yu HP, Shimizu T, Hsieh YC, Suzuki T, Choudhry MA, Schwacha MG, Chaudry IH: Tissue-specific expression of estrogen receptors and their role in the regulation of neutrophil infiltration in various organs following trauma-hemorrhage. J Leukoc Biol 79:963-970, 2006.
86. Yu HP, Hsieh YC, Suzuki T, Shimizu T, Choudhry MA, Schwacha MG, Chaudry IH: Salutary effects of estrogen receptor-beta agonist on lung injury after trauma-hemorrhage. Am J Physiol Lung Cell Mol Physiol 290:L1004-L1009, 2006.
87. Hildebrand F, Hubbard WJ, Choudhry MA, Frink M, Pape HC, Kunkel SL, Chaudry IH: Kupffer cells and their mediators: the culprits in producing distant organ damage after trauma-hemorrhage. Am J Pathol 169:784-794, 2006.
88. Angele MK, Frantz MC, Chaudry IH: Gender and sex hormones influence the response to trauma and sepsis: potential therapeutic approaches. Clinics 61:479-488, 2006.
89. Angele MK, Nitsch S, Knoferl MW, Ayala A, Angele P, Schildberg FW, Jauch KW, Chaudry IH: Sex-specific p38 MAP kinase activation following trauma-hemorrhage: involvement of testosterone and estradiol. Am J Physiol Endocrinol Metab 285:E189-E196, 2003.
90. Hildebrand F, Hubbard WJ, Choudhry MA, Thobe BM, Pape HC, Chaudry IH: Effects of 17beta-estradiol and flutamide on inflammatory response and distant organ damage following trauma-hemorrhage in metestrus females. J Leukoc Biol 80:759-765, 2006.
91. Szalay L, Shimizu T, Suzuki T, Hsieh YC, Choudhry MA, Schwacha MG, Bland KI, Chaudry IH: Androstenediol administration after trauma-hemorrhage attenuates inflammatory response, reduces organ damage, and improves survival following sepsis. Am J Physiol Gastrointest Liver Physiol 291:G260-G266, 2006.
92. Yang S, Hu S, Hsieh YC, Choudhry MA, Rue LW, Bland KI, Chaudry IH: Mechanism of IL-6-mediated cardiac dysfunction following trauma-hemorrhage. J Mol Cell Cardiol 40:570-579, 2006.
93. Angele MK, Chaudry IH: Surgical trauma and immunosuppression: pathophysiology and potential immunomodulatory approaches. Langenbecks Arch Surg 390:333-341, 2005.
94. Hubbard WJ, Bland KI, Chaudry IH: The role of the mitochondrion in trauma and shock. Shock 22:395-402, 2004.
95. Jarrar D, Kuebler JF, Rue LW, Matalon S, Wang P, Bland KI, Chaudry IH: Alveolar macrophage activation after trauma-hemorrhage and sepsis is dependent on NF-kappaB and MAPK/ERK mechanisms. Am J Physiol Lung Cell Mol Physiol 283:L799-L805, 2002.
96. Kuebler JF, Toth B, Yokoyama Y, Bland KI, Rue LW III, Chaudry IH: Alpha1-acid-glycoprotein protects against trauma-hemorrhagic shock. J Surg Res 119:21-28, 2004.
97. Meldrum DR: Tumor necrosis factor in the heart. Am J Physiol 274:R577-R595, 1998.
98. Tsai BM ME, Crisostomo PR, Wang M, Ketan M, Meldrum DR: Selective protein kinase C inhibition attenuates pulmonary artery cytokine expression without affecting hypoxic pulmonary vasoconstriction. Shock 27:36-39, 2007.
99. Markel TA, Crisostomo PR, Wairiuko GM, Pitcher J, Tsai BM, Meldrum DR: Cytokines in necrotizing enterocolitis. Shock 25:329-337, 2006.
100. Crisostomo PR, Wang M, Wairiuko GM, Morrell ED, Terrell AM, Seshadri P, Nam UH, Meldrum DR: High passage number of stem cells adversely affects stem cell activation and myocardial protection. Shock 26:575-580, 2006.
101. Crisostomo PR, Wang M, Herring CM, Morrell ED, Seshadri P, Meldrum KK, Meldrum DR: Sex dimorphisms in activated mesenchymal stem cell function. Shock 26:571-574, 2006.
102. Terrell AM, Crisostomo PR, Wairiuko GM, Wang M, Morrell ED, Meldrum DR: Jak/STAT/SOCS signaling circuits and associated cytokine-mediated inflammation and hypertrophy in the heart. Shock 26:226-234, 2006.
103. Wang M, Crisostomo P, Wairiuko GM, Meldrum DR: Estrogen receptor-alpha mediates acute myocardial protection in females. Am J Physiol Heart Circ Physiol 290:H2204-H2209, 2006.
104. Kher A, Wang M, Tsai BM, Pitcher JM, Greenbaum ES, Nagy RD, Patel KM, Wairiuko GM, Markel TA, Meldrum DR: Sex differences in the myocardial inflammatory response to acute injury. Shock 23:1-10, 2005.
105. Tsai BM, Wang M, Pitcher JM, Kher A, Crisostomo P, Meldrum DR: Zaprinast attenuates hypoxic pulmonary artery injury and causes less aortic relaxation than milrinone. Shock 24:417-420, 2005.
106. Tsai BM, Wang M, March KL, Turrentine MW, Brown JW, Meldrum DR: Preconditioning: evolution of basic mechanisms to potential therapeutic strategies. Shock 21:195-209, 2004.
107. Wang M, Sankula R, Tsai BM, Meldrum KK, Turrentine M, March KL, Brown JW, Dinarello CA, Meldrum DR: P38 MAPK mediates myocardial proinflammatory cytokine production and endotoxin-induced contractile suppression. Shock 21:170-174, 2004.
108. Hsieh YC, Yu HP, Suzuki T, Choudhry MA, Schwacha MG, Bland KI, Chaudry IH: Upregulation of mitochondrial respiratory complex IV by estrogen receptor-beta is critical for inhibiting mitochondrial apoptotic signaling and restoring cardiac functions following trauma-hemorrhage. J Mol Cell Cardiol 41:511-521, 2006.
109. Ayala A, Chung CS, Song GY, Chaudry IH: IL-10 mediation of activation-induced TH1 cell apoptosis and lymphoid dysfunction in polymicrobial sepsis. Cytokine 14:37-48, 2001.
110. Angele MK, Xu YX, Ayala A, Schwacha MG, Catania RK, Cioffi WG, Bland KI, Chaudry IH: Gender dimorphism in trauma-hemorrhage-induced thymocyte apoptosis. Shock 12:316-322, 1999.
111. Chung CS, Wang W, Chaudry IH, Ayala A: Increased apoptosis in lamina propria B cells during polymicrobial sepsis is FasL but not endotoxin mediated. Am J Physiol Gastrointest Liver Physiol 280:G812-G818, 2001.
112. Thickett DR, Armstrong L, Christie SJ, Millar AB: Vascular endothelial growth factor may contribute to increased vascular permeability in acute respiratory distress syndrome. Am J Respir Crit Care Med 164:1601-1605, 2001.
113. Kunig AM, Balasubramaniam V, Markham NE, Seedorf G, Gien J, Abman SH: Recombinant human VEGF treatment transiently increases lung edema but enhances lung structure after neonatal hyperoxia. Am J Physiol Lung Cell Mol Physiol 291:L1068-L1078, 2006.
114. Hamada N, Kuwano K, Yamada M, Hagimoto N, Hiasa K, Egashira K, Nakashima N, Maeyama T, Yoshimi M, Nakanishi Y: Anti-vascular endothelial growth factor gene therapy attenuates lung injury and fibrosis in mice. J Immunol 175:1224-1231, 2005.
115. van der Flier M, van Leeuwen HJ, van Kessel KP, Kimpen JL, Hoepelman AI, Geelen SP: Plasma vascular endothelial growth factor in severe sepsis. Shock 23:35-38, 2005.
116. Pickkers P, Sprong T, Eijk L, Hoeven H, Smits P, Deuren M: Vascular endothelial growth factor is increased during the first 48 hours of human septic shock and correlates with vascular permeability. Shock 24:508-512, 2005.
117. van Eijk LT, Nooteboom A, Hendriks T, Sprong T, Netea MG, Smits P, van der Hoeven JG, Pickkers P: Plasma obtained during human endotoxemia increases endothelial albumin permeability in vitro. Shock 25:358-362, 2006.
118. Medford AR, Millar AB: Vascular endothelial growth factor (VEGF) in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): paradox or paradigm? Thorax 61:621-626, 2006.
119. Maitre B, Boussat S, Jean D, Gouge M, Brochard L, Housset B, Adnot S, Delclaux C: Vascular endothelial growth factor synthesis in the acute phase of experimental and clinical lung injury. Eur Respir J 18:100-106, 2001.
120. Corne J, Chupp G, Lee CG, Homer RJ, Zhu Z, Chen Q, Ma B, Du Y, Roux F, McArdle J, et al.: IL-13 stimulates vascular endothelial cell growth factor and protects against hyperoxic acute lung injury. J Clin Invest 106:783-791, 2000.
121. Tuder RM, Groves B, Badesch DB, Voelkel NF: Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension. Am J Pathol 144:275-285, 1994.
122. Geiger R, Berger RM, Hess J, Bogers AJ, Sharma HS, Mooi WJ: Enhanced expression of vascular endothelial growth factor in pulmonary plexogenic arteriopathy due to congenital heart disease. J Pathol 191:202-207, 2000.
123. Tuder RM, Chacon M, Alger L, Wang J, Taraseviciene-Stewart L, Kasahara Y, Cool CD, Bishop AE, Geraci M, Semenza GL, et al.: Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis. J Pathol 195:367-374, 2001.
124. Hirose S, Hosoda Y, Furuya S, Otsuki T, Ikeda E: Expression of vascular endothelial growth factor and its receptors correlates closely with formation of the plexiform lesion in human pulmonary hypertension. Pathol Int 50:472-479, 2000.
125. Partovian C, Adnot S, Raffestin B, Louzier V, Levame M, Mavier IM, Lemarchand P, Eddahibi S: Adenovirus-mediated lung vascular endothelial growth factor overexpression protects against hypoxic pulmonary hypertension in rats. Am J Respir Cell Mol Biol 23:762-771, 2000.
126. Zaiman AL, Tuder RM: Hypoxia-sensitive transcription factors and growth factors. In Yuan JXJ, Norwell MA (eds.): Hypoxic Pulmonary Vasoconstriction. Kluwer Academic, pp 437-447, 2004.
127. Arcot SS, Lipke DW, Gillespie MN, Olson JW: Alterations of growth factor transcripts in rat lungs during development of monocrotaline-induced pulmonary hypertension. Biochem Pharmacol 46:1086-1091, 1993.
128. Partovian C, Ladoux A, Eddahibi S, Teiger E, Raffestin B, Frelin C, Adnot S: Cardiac and lung VEGF mRNA expression in chronically hypoxic and monocrotaline-treated rats. Chest 114(suppl):45-46, 1998.
129. Partovian C, Adnot S, Eddahibi S, Teiger E, Levame M, Dreyfus P, Raffestin B, Frelin C: Heart and lung VEGF mRNA expression in rats with monocrotaline- or hypoxia-induced pulmonary hypertension. Am J Physiol 275:H1948-H1956, 1998.
130. Fujita M, Mason RJ, Cool C, Shannon JM, Hara N, Fagan KA: Pulmonary hypertension in TNF-alpha-overexpressing mice is associated with decreased VEGF gene expression. J Appl Physiol 93:2162-2170, 2002.
131. Taraseviciene-Stewart L, Gera L, Hirth P, Voelkel NF, Tuder RM, Stewart JM: A bradykinin antagonist and a caspase inhibitor prevent severe pulmonary hypertension in a rat model. Can J Physiol Pharmacol 80:269-274, 2002.
132. Taraseviciene-Stewart L, Kasahara Y, Alger L, Hirth P, Mc Mahon G, Waltenberger J, Voelkel NF, Tuder RM: Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension. FASEB J 15:427-438, 2001.
133. Sakao S, Taraseviciene-Stewart L, Lee JD, Wood K, Cool CD, Voelkel NF: Initial apoptosis is followed by increased proliferation of apoptosis-resistant endothelial cells. FASEB J 19:1178-1180, 2005.
134. Sakao S, Taraseviciene-Stewart L, Wood K, Cool CD, Voelkel NF: Apoptosis of pulmonary microvascular endothelial cells stimulates vascular smooth muscle cell growth. Am J Physiol Lung Cell Mol Physiol 291:L362-L368, 2006.
135. Campbell AI, Zhao Y, Sandhu R, Stewart DJ: Cell-based gene transfer of vascular endothelial growth factor attenuates monocrotaline-induced pulmonary hypertension. Circulation 104:2242-2248, 2001.
136. Gong F, Tang H, Lin Y, Gu W, Wang W, Kang M: Gene transfer of vascular endothelial growth factor reduces bleomycin-induced pulmonary hypertension in immature rabbits. Pediatr Int 47:242-247, 2005.
137. Grover TR, Parker TA, Markham NE, Abman SH: rhVEGF treatment preserves pulmonary vascular reactivity and structure in an experimental model of pulmonary hypertension in fetal sheep. Am J Physiol Lung Cell Mol Physiol 289:L315-L321, 2005.
138. Taraseviciene-Stewart L, Scerbavicius R, Choe KH, Cool C, Wood K, Tuder RM, Burns N, Kasper M, Voelkel NF: Simvastatin causes endothelial cell apoptosis and attenuates severe pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 291:L668-L676, 2006.
139. Louzier V, Raffestin B, Leroux A, Branellec D, Caillaud JM, Levame M, Eddahibi S, Adnot S: Role of VEGF-B in the lung during development of chronic hypoxic pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 284:L926-L937, 2003.
140. Tuder RM, Yeager ME, Geraci M, Golpon HA, Voelkel NF: Severe pulmonary hypertension after the discovery of the familial primary pulmonary hypertension gene. Eur Respir J 17:1065-1069, 2001.
141. Zaiman A, Fijalkowska I, Hassoun PM, Tuder RM: One hundred years of research in the pathogenesis of pulmonary hypertension. Am J Respir Cell Mol Biol 33:425-431, 2005.
142. Kasahara Y, Tuder RM, Cool CD, Lynch DA, Flores SC, Voelkel NF: Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. Am J Respir Crit Care Med 163:737-744, 2001.
143. Kasahara Y, Tuder RM, Taraseviciene-Stewart L, Le Cras TD, Abman S, Hirth PK, Waltenberger J, Voelkel NF: Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest 106:1311-1319, 2000.
144. Koyama S, Sato E, Haniuda M, Numanami H, Nagai S, Izumi T: Decreased level of vascular endothelial growth factor in bronchoalveolar lavage fluid of normal smokers and patients with pulmonary fibrosis. Am J Respir Crit Care Med 166:382-385, 2002.
145. Liebow AA: Pulmonary emphysema with special reference to vascular changes. Am Rev Respir Dis 80:67-93, 1959.
146. Tuder RM, Wood K, Taraseviciene L, Flores SC, Voekel NF: Cigarette smoke extract decreases the expression of vascular endothelial growth factor by cultured cells and triggers apoptosis of pulmonary endothelial cells. Chest 117(suppl):241-242, 2000.
147. Tuder RM, Zhen L, Cho CY, Taraseviciene-Stewart L, Kasahara Y, Salvemini D, Voelkel NF, Flores SC: Oxidative stress and apoptosis interact and cause emphysema due to vascular endothelial growth factor receptor blockade. Am J Respir Cell Mol Biol 29:88-97, 2003.
148. Voelkel NF, Quaife RA, Leinwand LA, Barst RJ, McGoon MD, Meldrum DR, Dupuis J, Long CS, Rubin LJ, Smart FW, et al.: Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. Circulation 114:1883-1891, 2006.